Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Altered p53 regulation of miR-148b and p55PIK contributes to tumor progression in colorectal cancer.

Authors: Wang, G  Cao, X  Lai, S  Luo, X  Feng, Y  Wu, J  Ning, Q  Xia, X  Wang, J  Gong, J  Hu, J 
Citation: Wang G, etal., Oncogene. 2015 Feb 12;34(7):912-21. doi: 10.1038/onc.2014.30. Epub 2014 Mar 17.
Pubmed: (View Article at PubMed) PMID:24632606
DOI: Full-text: DOI:10.1038/onc.2014.30

MicroRNAs are a class of small non-coding RNAs that regulate the expressions of many genes. Previously, we found that the expression of p55PIK, an isoform of phosphatidylinosotol 3-kinase that has important roles in the regulation of cell cycle, is increased significantly in several types of cancer and contributes to the tumor growth. However, the mechanism for this increased p55PIK expression is not well understood. In this study, we show that miR-148b binds specifically to the 3'-untranslated region of p55PIK and significantly suppresses p55PIK expression. MiR-148b overexpression abolished p55PIK stimulation of cell proliferation and cell cycle progression in colorectal cancer (CRC) cell lines and decreased tumor growth in vivo. Furthermore, we demonstrated that p53 directly activates the transcription of miR-148b by binding to its promoter. In CRC cell lines and tissues, p53 expression was associated with miR-148b expression, and both were negatively associated with p55PIK expression. Our study shows that the p53/miR-148b/p55PIK axis has an important role in cell proliferation and tumor growth, and may represent a novel therapeutic target for treating cancers containing p53 mutations or losses.

Annotation

Disease Annotations
Objects Annotated

Additional Information

 
CRRD Object Information
CRRD ID: 13432053
Created: 2017-09-14
Species: All species
Last Modified: 2017-09-14
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.